FY2025 EPS Estimates for Organigram Cut by Atb Cap Markets

Organigram Holdings Inc. (TSE:OGI) – Equities research analysts at Atb Cap Markets dropped their FY2025 earnings per share estimates for Organigram in a research report issued on Monday, December 16th. Atb Cap Markets analyst F. Gomes now anticipates that the company will earn ($0.13) per share for the year, down from their prior forecast of ($0.12). The consensus estimate for Organigram’s current full-year earnings is $0.16 per share.

A number of other equities research analysts also recently commented on the stock. ATB Capital cut their target price on shares of Organigram from C$5.25 to C$3.50 in a research report on Tuesday. Canaccord Genuity Group reduced their target price on shares of Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating for the company in a report on Monday, December 9th.

Organigram Stock Performance

OGI traded up C$0.10 during midday trading on Thursday, hitting C$2.20. 71,111 shares of the company traded hands, compared to its average volume of 295,383. The company’s 50-day moving average is C$2.26 and its 200 day moving average is C$2.30. Organigram has a 52 week low of C$1.61 and a 52 week high of C$3.95. The firm has a market capitalization of C$238.85 million, a PE ratio of -0.88, a price-to-earnings-growth ratio of 0.42 and a beta of 1.13. The company has a quick ratio of 2.62, a current ratio of 6.95 and a debt-to-equity ratio of 1.13.

Insider Transactions at Organigram

In other Organigram news, Senior Officer Paolo De Luca sold 12,014 shares of the firm’s stock in a transaction on Thursday, October 24th. The stock was sold at an average price of C$2.52, for a total transaction of C$30,275.28. Company insiders own 31.32% of the company’s stock.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.